SCOPUS 정보 검색 플랫폼

Seminars in Hematology

Volumn 38, Issue 1 SUPPL. 1, 2001, Pages 63-68

Deferoxamine pharmacokinetics

(1) Porter, John B a

a UNIVERSITY COLLEGE LONDON (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE MESYLATE; FERRIOXAMINE; FERRITIN;

BETA THALASSEMIA; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0035138693 PISSN: 00371963 EISSN: None Source Type: Journal
DOI: 10.1016/s0037-1963(01)90061-7 Document Type: Conference Paper

Times cited : (61)

References (15)

1
- 0023220354
- Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis
- (1987) Br J Clin Pharmacol , vol.24 , pp. 207-212
- Allain, P.¹ Mauras, Y.² Chaleil, D.³

2
- 0021707996
- Ocular changes in patients undergoing long-term desferrioxamine treatment
- (1984) Br J Opthalmol , vol.68 , pp. 873-877
- Arden, G.B.¹ Wonke, B.² Kennedy, C.³

3
- 0006206840
- Proceedings of the 9th International Conference on Oral Chelation, March 1999, Hamburg, Germany
- Unbound iron binding capacity: Correlation with non-transferrin bound plasma iron and deferoxamine levels
- Gee, B.¹ Law, T.² Kurth, S.³

4
- 0027291099
- Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemia patients
- (1993) Drugs Metab Disp , vol.21 , pp. 640-644
- Lee, P.¹ Mohammed, N.² Abeysinghe, R.D.³

5
- 0018183383
- Intensive iron-chelation with desferrioxamine in iron-loading anaemias
- (1978) Clin Sci Mol Med , vol.54 , pp. 99-106
- Pippard, M.J.¹ Callender, S.T.² Weatherall, D.J.³

6
- 0000644975
- Subcutaneous depot desferrioxamine (CGH 749B): Relationship of pharmacokinetics to efficacy and drug metabolism
- abstr 1163
- (1997) Blood , vol.90
- Porter, J.B.¹ Alberti, D.² Hassan, I.³

7
- 0031873072
- A trial to investigate the relationship between DFO pharmacokinetics and metabolism and DFO-related toxicity
- (1998) Ann NY Acad Sci , vol.850 , pp. 486-490
- Porter, J.¹ Faherty, A.² Stallibrass, L.³

8
- 0023613154
- Transfusion and exchange transfusion in sickle cell anaemia, with particular reference to iron metabolism
- (1987) Acta Haematol , vol.78 , pp. 198-205
- Porter, J.¹ Huehns, E.²

9
- 0001483303
- Iron balance and chelation efficiency following single dose depot desferrioxamine
- suppl 1, abstr 1334
- (1998) Blood , vol.92
- Porter, J.¹ Weir, D.² Davis, B.³

10
- 0017077213
- Reassessment of the use of desferrioxamine B in iron overload
- (1976) N Engl J Med , vol.294 , pp. 1421-1423
- Propper, R.D.¹ Shurin, S.B.² Nathan, D.G.³

11
- 0017622851
- Continuous subcutaneous administration of deferoxamine in patients with iron overload
- (1977) N Engl J Med , vol.297 , pp. 418-423
- Propper, R.¹ Cooper, B.² Rufo, R.³

12
- 0025302418
- Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chroma. Tography and fast atom bombardment mass spectrometry
- (1990) Anal Biochem , vol.187 , pp. 1-8
- Singh, S.¹ Hider, R.C.² Porter, J.B.³

13
- 0026769718
- Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detection
- (1992) Anal Biochem , vol.203 , pp. 116-120
- Singh, S.¹ Mohammed, N.² Ackerman, R.³

14
- 0018777993
- Studies in desferrioxamine and ferrioxamine metabolism in normal and iron loaded subjects
- (1979) Br J Haematol , vol.42 , pp. 547-555
- Summers, M.¹ Jacobs, A.² Tudway, D.³

15
- 0006206841
- The effect of low dose desferrioxamine on toxicity in hemoglobinopathy patients. Sickle cell disease and thalassaemias: New trends in therapy
- (1995) Colloque INSERM , vol.234 , pp. 377-378
- Styles, L.¹ Vichinsky, E.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.